首页> 美国卫生研究院文献>Journal of Obesity Metabolic Syndrome >Intermittent Fasting: Current Evidence in Clinical Practice
【2h】

Intermittent Fasting: Current Evidence in Clinical Practice

机译:间歇性禁食:临床实践的最新证据

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Intermittent fasting (IF), or time-restricted feeding, is an emerging dietary intervention that restricts intake of food and energy for a given period. Not only does this method restrict total caloric intake, it also promotes metabolic homeostasis by supporting circadian feeding rhythms. , Only in the most recent 200 years have humans been able to access supplies of vast amounts of food and resources, which has caused a shift in disease patterns, particularly for metabolic syndromes and obesity. The idea that reducing caloric intake can result in evolutionary cellular responses for survival has been an active research topic, but with the recent public awareness and interest in IF, many clinical studies have been published more recently. On December 2019, de Cabo and Mattson published a review article that discusses the mechanisms and current clinical evidence for IF. This review article discusses various broad-spectrum benefits of IF, with a positive outlook for more clinical evidence in the future.
机译:间歇性禁食(IF)或限时喂食是一种新兴的饮食干预措施,在一定时期内会限制食物和能量的摄入。这种方法不仅限制了总热量的摄入,而且还通过支持昼夜节食的饮食节奏来促进代谢稳态。 ,仅在最近的200年中,人类才能够获得大量食物和资源,这已导致疾病模式的转变,特别是对于代谢综合征和肥胖症。减少热量摄入可导致存活细胞进化的想法一直是一个活跃的研究主题,但是随着近来公众对IF的认识和兴趣,近来已发表了许多临床研究。 2019年12月,de Cabo和Mattson发表了一篇评论文章,讨论了IF的机制和当前的临床证据。这篇综述文章讨论了IF的各种广谱益处,并在未来获得更多临床证据的积极前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号